GlassScriptPhysician profile
Atur Patel
NPI 1689036683
$6,057.03
in general payments reported to CMS, 2019-2025
21 companies · $1,628 in 2025
The $1,628 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $1,476 · 2023: $1,361 · 2024: $1,235 · 2025: $1,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,223.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,070.24 | 2021-2025 | Nucala |
| Jazz Pharmaceuticals INC. | $763.28 | 2021-2024 | |
| Inspire Medical Systems, INC. | $732.45 | 2021-2025 | Inspire |
| Axsome Therapeutics, INC. | $726.42 | 2023-2025 | Sunosi |
| Optinose US, INC. | $701.66 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $537.10 | 2022-2025 | Dupixent |
| Integra Lifesciences Corporation | $405.50 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Genzyme Corporation | $324.65 | 2022-2025 | |
| Daiichi Sankyo INC. | $187.87 | 2021-2022 | |
| Aerin Medical INC. | $137.46 | 2024-2025 | |
| Harmony Biosciences LLC | $106.57 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $69.39 | 2025 | Tezspire |
| Neurent Medical Limited | $62.61 | 2022 | |
| Lilly USA, LLC | $45.04 | 2025 | Zepbound |
| Smith+Nephew, INC. | $41.84 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $34.79 | 2024-2025 | |
| Acclarent, INC | $32.44 | 2023-2024 | Relieva Spinplus |
| Ars Pharmaceuticals Operations, INC. | $29.68 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $18.83 | 2025 | Coolseal Generator |
| Avadel Cns Pharmaceuticals, LLC | $15.26 | 2024 | Lumryz |
| Paratek Pharmaceuticals, INC. | $13.95 | 2025 | Xhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atur Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.